Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Description and analysis of the VA National Formulary [[electronic resource] /] / David Blumenthal and Roger Herdman, editors ; VA Pharmacy Formulary Analysis Committee, Division of Health Care Services, Institute of Medicine
| Description and analysis of the VA National Formulary [[electronic resource] /] / David Blumenthal and Roger Herdman, editors ; VA Pharmacy Formulary Analysis Committee, Division of Health Care Services, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, c2000 |
| Descrizione fisica | xvi, 262 p. : ill |
| Altri autori (Persone) |
BlumenthalDavid <1948->
HerdmanRoger |
| Soggetto topico |
Drugs - United States
Drug utilization - Government policy - United States Medicine Veterans - Medical care - United States - Quality control |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-18551-1
9786610185511 0-309-56964-8 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910456345303321 |
| Washington, D.C., : National Academy Press, c2000 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Description and analysis of the VA National Formulary / / David Blumenthal and Roger Herdman, editors ; VA Pharmacy Formulary Analysis Committee, Division of Health Care Services, Institute of Medicine
| Description and analysis of the VA National Formulary / / David Blumenthal and Roger Herdman, editors ; VA Pharmacy Formulary Analysis Committee, Division of Health Care Services, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C. : , : National Academy Press, , 2000 |
| Descrizione fisica | xvi, 262 pages : illustrations |
| Altri autori (Persone) |
BlumenthalDavid <1948->
HerdmanRoger |
| Soggetto topico |
Drugs - United States
Drug utilization - Government policy - United States Medicine Veterans - Medical care - United States - Quality control |
| ISBN |
0-309-18353-7
1-280-18551-1 9786610185511 0-309-56964-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910778629803321 |
| Washington, D.C. : , : National Academy Press, , 2000 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Description and analysis of the VA National Formulary / / David Blumenthal and Roger Herdman, editors ; VA Pharmacy Formulary Analysis Committee, Division of Health Care Services, Institute of Medicine
| Description and analysis of the VA National Formulary / / David Blumenthal and Roger Herdman, editors ; VA Pharmacy Formulary Analysis Committee, Division of Health Care Services, Institute of Medicine |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, c2000 |
| Descrizione fisica | xvi, 262 pages : illustrations |
| Altri autori (Persone) |
BlumenthalDavid <1948->
HerdmanRoger |
| Soggetto topico |
Drugs - United States
Drug utilization - Government policy - United States Medicine Veterans - Medical care - United States - Quality control |
| ISBN |
0-309-18353-7
1-280-18551-1 9786610185511 0-309-56964-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
DESCRIPTION AND ANALYSIS OF THE VA National Formulary -- Copyright -- Preface -- REVIEWERS -- Contents -- Executive Summary -- SUMMARY AND CONCLUSIONS -- Restrictiveness -- Cost -- Quality -- Comparisons -- Recommendations -- 1 Introduction -- LEGISLATIVE AND EXECUTIVE BRANCH HISTORY -- History of the IOM Study -- The IOM Committee -- FORMULARIES AND FORMULARY SYSTEMS: HISTORY AND DEFINITIONS -- Modern Formularies and Formulary Systems -- Economic Focus of Formularies -- Types of Formularies and Their Restrictiveness -- Formulary Control -- GENERIC SUBSTITUTION -- THERAPEUTIC INTERCHANGE -- LOCAL VA FACILITY AND VISN FORMULARIES AND THE NATIONAL FORMULARY -- History of VA Formulary Management Prior to the National Formulary -- Reorganization of the VA -- Impact of the VA Fixed Budget -- Establishing the VA National Formulary -- Evolution of the National Formulary -- Medical Staff Input -- National Formulary Classes -- Formulary Relationship to Pharmaceutical Companies -- REPORT OUTLINE -- 2 Is the VA National Formulary Overly Restrictive and Does It Prevent Physicians from Meeting the Health Care Needs of… -- BACKGROUND -- Elements of Restrictiveness -- SIZE AND COVERAGE OF THE NATIONAL FORMULARY -- Adequacy of the VA National Formulary -- Closed and Preferred Drug Classes in the VA -- Restrictiveness of Class Closure -- Excluded Drugs and Other Limits -- National Formulary Effects on Drug Use -- ADDITION OF NEW DRUGS AND FORMULARY REAPPRAISAL -- National Policy Regarding New Drugs -- VISN Addition of New FDA Approvals -- Evaluation of the VA Process for Adding New FDA-Approved Priority Drugs -- Addition of Existing Drugs by the VA -- Addition of Newly Approved or Existing Drugs in Other Health Care Systems -- THE NONFORMULARY PROCESS -- THERAPEUTIC INTERCHANGE -- OTC DRUG COVERAGE, GENERIC SUBSTITUTION, AND PHYSICIAN SATISFACTION.
Generic Substitution -- Veterans' Complaints -- VA Physician Satisfaction -- SUMMARY -- 3 What Are the Potential Costs to VA Health Care Associated with the National Formulary for Drugs? -- INTRODUCTION -- THE VHA NATIONAL FORMULARY AS IT AFFECTS COSTS -- Background -- Basic Economics of the VA National Formulary -- Features of the National Formulary -- VISN Implementation Issues -- Other Influences on VHA Pharmaceutical Spending -- ANALYTICAL FRAMEWORK -- DATA -- EMPIRICAL METHODS -- RESULTS OF THE IOM COMMITTEE ANALYSIS OF COST EFFECTS -- How Have the VHA and the Veteran User Population Changed During the Study Period? -- How Has the National Formulary Affected Prices for Closed and Preferred Classes? -- How Has the National Formulary Affected Prescribing Patterns Within the Closed and Preferred Classes? -- How Has the National Formulary Affected Pharmaceutical Spending per Veteran User for Closed and Preferred Classes? -- IS THERE EVIDENCE THAT CHANGES IN FORMULARY POLICY HAVE RESULTED IN INCREASED UTILIZATION ELSEWHERE IN THE VHA SYSTEM? -- Exploration of Changes in Hospital Discharges per VHA User -- COSTS ASSOCIATED WITH IMPLEMENTING AND MANAGING THE NATIONAL FORMULARY -- Estimated National Formulary Savings -- CONCLUSIONS -- 4 What Are the Effects of the National Formulary and Related Policies on Quality of Care? -- BACKGROUND INFORMATION -- Sources of Quality Data -- QUALITY OF CARE IN THE VHA AND EFFECTS OF THE NATIONAL FORMULARY -- PHARMACY, CLINICAL, AND FORMULARY PROGRAM ELEMENTS RELEVANT TO QUALITY OF CARE -- Clinical Pharmacy -- P& -- T COMMITTEES -- THE VA PBM COMPLEX -- Additions to, and Quality of, the National Formulary -- POLICIES AND PROCEDURES -- Drug Class Reviews -- Clinical Guidelines and Drug Utilization Reviews -- The Nonformulary Process -- Therapeutic Interchange, Policy, and Results. EFFECTS OF THE NATIONAL FORMULARY ON USE OF DRUGS BY THE VA -- ADVERSE DRUG EVENTS -- Changes in Inpatient Hospital Discharges Associated with the National Formulary -- PATIENT COMPLAINTS-ADVOCATE, VETERANS OF FOREIGN WARS, AND SURVEY DATA -- PHYSICIAN COMPLAINTS AND SURVEY DATA -- SUMMARY STATEMENT -- 5 How Does the VA National Formulary Compare with Private Insurance Formularies for Drugs and Devices and with Other… -- INTRODUCTION -- IMPLEMENTATION OF DRUG MANAGEMENT STRATEGIES IN MANAGED CARE -- IMPACT OF STATE LEGISLATION ON MCO PRACTICE -- PUBLIC-SECTOR PROGRAMS -- Medicaid -- Medicaid Fee for Service -- Medicaid Prescription Drug Benefit -- Medicaid Controls Prior Approval and Formulary Systems -- Comparison to the VA -- Effects of Medicaid Formularies and Formulary Systems -- Effects of Medicaid Prior Approval Systems -- Effects of Medicaid Prescription Limits -- Medicaid Managed Care: Background -- Drug Benefit in Medicaid Managed Care -- DEPARTMENT OF DEFENSE -- Health Care System and Pharmacy Benefit -- DOD Formulary and Formulary System -- GENERAL COMMENTS ON COMPARISONS -- 6 The VA National Formulary and Veterans Health Care -- INTRODUCTION -- BACKGROUND AND CONTEXT -- THE VETERANS HEALTH ADMINISTRATION -- RESTRICTIVENESS -- COSTS -- QUALITY -- COMPARISONS -- References -- Acronyms -- APPENDIX A Interim Report of the Committee on VA Pharmacy Formulary Analysis to the Department of Veterans Affairs and the… -- JANUARY 28, 2000 -- APPENDIX B Academy of Managed Care Pharmacy's Managed Care Formulary and Pharmacy Benefit Design Survey -- AMCP MANAGED CARE FORMULARY AND PHARMACY BENEFIT DESIGN SURVEY (JANUARY 2000) -- The P& -- T Committee -- Exclusion of Coverage -- Closed Formularies -- Open-Preferred Formularies -- Open-Passive Formularies -- Other Types of Formularies -- Drug Restrictions -- Generic Drugs. Access to Nonformulary Drugs -- Cost-Containment Measures -- Addition of New FDA-Approved Drugs -- Appeals Process -- Continuation of Care -- APPENDIX C Additional Cost Information -- APPENDIX D Glossary -- APPENDIX E Drug Classes and Drug Index -- DRUG CLASSES -- OTHER DRUGS -- Committee Biographies. |
| Altri titoli varianti |
VA National Formulary
Veterans Administration National Formulary |
| Record Nr. | UNINA-9910810864103321 |
| Washington, D.C., : National Academy Press, c2000 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Effect of the HIPAA privacy rule on health research [[electronic resource] ] : proceedings of a workshop presented to the National Cancer Policy Forum / / National Cancer Policy Forum ; Roger Herdman and Harold Moses, rapporteurs ; Institute of Medicine of the National Academies
| Effect of the HIPAA privacy rule on health research [[electronic resource] ] : proceedings of a workshop presented to the National Cancer Policy Forum / / National Cancer Policy Forum ; Roger Herdman and Harold Moses, rapporteurs ; Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington D.C., : National Academies Press, c2006 |
| Descrizione fisica | 1 online resource (102 p.) |
| Disciplina | 651.5 |
| Altri autori (Persone) |
HerdmanRoger
MosesHarold L |
| Soggetto topico |
Health - Research - Access control
Medical records - Access control Privacy |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-60449-2
9786610604494 0-309-66387-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Front Matter""; ""Contents""; ""1 Introduction""; ""2 Prepared Presentations and Discussion""; ""Glossary""; ""Appendix Workshop Agenda"" |
| Record Nr. | UNINA-9910452047203321 |
| Washington D.C., : National Academies Press, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Effect of the HIPAA privacy rule on health research [[electronic resource] ] : proceedings of a workshop presented to the National Cancer Policy Forum / / National Cancer Policy Forum ; Roger Herdman and Harold Moses, rapporteurs ; Institute of Medicine of the National Academies
| Effect of the HIPAA privacy rule on health research [[electronic resource] ] : proceedings of a workshop presented to the National Cancer Policy Forum / / National Cancer Policy Forum ; Roger Herdman and Harold Moses, rapporteurs ; Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington D.C., : National Academies Press, c2006 |
| Descrizione fisica | 1 online resource (102 p.) |
| Disciplina | 651.5 |
| Altri autori (Persone) |
HerdmanRoger
MosesHarold L |
| Soggetto topico |
Health - Research - Access control
Medical records - Access control Privacy |
| ISBN |
0-309-18069-4
1-280-60449-2 9786610604494 0-309-66387-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Front Matter""; ""Contents""; ""1 Introduction""; ""2 Prepared Presentations and Discussion""; ""Glossary""; ""Appendix Workshop Agenda"" |
| Record Nr. | UNINA-9910777605303321 |
| Washington D.C., : National Academies Press, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Effect of the HIPAA privacy rule on health research : proceedings of a workshop presented to the National Cancer Policy Forum / / National Cancer Policy Forum ; Roger Herdman and Harold Moses, rapporteurs ; Institute of Medicine of the National Academies
| Effect of the HIPAA privacy rule on health research : proceedings of a workshop presented to the National Cancer Policy Forum / / National Cancer Policy Forum ; Roger Herdman and Harold Moses, rapporteurs ; Institute of Medicine of the National Academies |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington D.C., : National Academies Press, c2006 |
| Descrizione fisica | 1 online resource (102 p.) |
| Disciplina | 651.5 |
| Altri autori (Persone) |
HerdmanRoger
MosesHarold L |
| Soggetto topico |
Health - Research - Access control
Medical records - Access control Privacy |
| ISBN |
0-309-18069-4
1-280-60449-2 9786610604494 0-309-66387-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Front Matter""; ""Contents""; ""1 Introduction""; ""2 Prepared Presentations and Discussion""; ""Glossary""; ""Appendix Workshop Agenda"" |
| Record Nr. | UNINA-9910820741903321 |
| Washington D.C., : National Academies Press, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Federal agency roles in cancer drug development from preclinical research to new drug approval [[electronic resource] ] : the National Cancer Institute and the Food and Drug Administration / / Joseph P. Newhouse, John Mendelsohn, Hellen Gelband and Roger Herdman
| Federal agency roles in cancer drug development from preclinical research to new drug approval [[electronic resource] ] : the National Cancer Institute and the Food and Drug Administration / / Joseph P. Newhouse, John Mendelsohn, Hellen Gelband and Roger Herdman |
| Autore | Newhouse Joseph P |
| Edizione | [3rd ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, c2005 |
| Descrizione fisica | 1 online resource (69 p.) |
| Altri autori (Persone) |
MendelsohnJohn M
GelbandHellen HerdmanRoger |
| Soggetto topico |
Antineoplastic agents - Development
Public administration - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN | 0-309-54976-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""FRONT MATTER""; ""Table of Contents""; ""1 SCIENTIFIC RATIONALE""; ""2 THE NATIONAL CANCER INSTITUTE""; ""3 THE FOOD AND DRUG ADMINISTRATION""; ""4 SUMMARY: THE ROLES OF THE NCI AND FDA IN DEVELOPING ANTICANCER AGENTS""; ""REFERENCES""; ""ACRONYMS AND ABBREVIATIONS"" |
| Record Nr. | UNINA-9910450324403321 |
Newhouse Joseph P
|
||
| Washington, D.C., : National Academy Press, c2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Federal agency roles in cancer drug development from preclinical research to new drug approval [[electronic resource] ] : the National Cancer Institute and the Food and Drug Administration / / Joseph P. Newhouse, John Mendelsohn, Hellen Gelband and Roger Herdman
| Federal agency roles in cancer drug development from preclinical research to new drug approval [[electronic resource] ] : the National Cancer Institute and the Food and Drug Administration / / Joseph P. Newhouse, John Mendelsohn, Hellen Gelband and Roger Herdman |
| Autore | Newhouse Joseph P |
| Edizione | [3rd ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, c2005 |
| Descrizione fisica | 1 online resource (69 p.) |
| Altri autori (Persone) |
MendelsohnJohn M
GelbandHellen HerdmanRoger |
| Soggetto topico |
Antineoplastic agents - Development
Public administration - United States |
| ISBN | 0-309-54976-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""FRONT MATTER""; ""Table of Contents""; ""1 SCIENTIFIC RATIONALE""; ""2 THE NATIONAL CANCER INSTITUTE""; ""3 THE FOOD AND DRUG ADMINISTRATION""; ""4 SUMMARY: THE ROLES OF THE NCI AND FDA IN DEVELOPING ANTICANCER AGENTS""; ""REFERENCES""; ""ACRONYMS AND ABBREVIATIONS"" |
| Record Nr. | UNINA-9910783331003321 |
|
Newhouse Joseph P
|
||
| Washington, D.C., : National Academy Press, c2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Federal agency roles in cancer drug development from preclinical research to new drug approval : the National Cancer Institute and the Food and Drug Administration / / Joseph P. Newhouse, John Mendelsohn, Hellen Gelband and Roger Herdman
| Federal agency roles in cancer drug development from preclinical research to new drug approval : the National Cancer Institute and the Food and Drug Administration / / Joseph P. Newhouse, John Mendelsohn, Hellen Gelband and Roger Herdman |
| Autore | Newhouse Joseph P |
| Edizione | [3rd ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, c2005 |
| Descrizione fisica | 1 online resource (69 p.) |
| Altri autori (Persone) |
MendelsohnJohn M
GelbandHellen HerdmanRoger |
| Soggetto topico |
Antineoplastic agents - Development
Public administration - United States |
| ISBN | 0-309-54976-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""FRONT MATTER""; ""Table of Contents""; ""1 SCIENTIFIC RATIONALE""; ""2 THE NATIONAL CANCER INSTITUTE""; ""3 THE FOOD AND DRUG ADMINISTRATION""; ""4 SUMMARY: THE ROLES OF THE NCI AND FDA IN DEVELOPING ANTICANCER AGENTS""; ""REFERENCES""; ""ACRONYMS AND ABBREVIATIONS"" |
| Record Nr. | UNINA-9910821185703321 |
|
Newhouse Joseph P
|
||
| Washington, D.C., : National Academy Press, c2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Fulfilling the potential of cancer prevention and early detection [[electronic resource] ] : an American Cancer Society and Institute of Medicine Symposium / / Roger Herdman and Leonard Lichtenfeld, editors ; National Cancer Policy Board
| Fulfilling the potential of cancer prevention and early detection [[electronic resource] ] : an American Cancer Society and Institute of Medicine Symposium / / Roger Herdman and Leonard Lichtenfeld, editors ; National Cancer Policy Board |
| Pubbl/distr/stampa | Washington, DC, : National Academies Press, c2004 |
| Descrizione fisica | viii, 128 p. : ill |
| Disciplina | 362.196/994 |
| Altri autori (Persone) |
HerdmanRoger
LichtenfeldLeonard |
| Soggetto topico |
Cancer - United States - Prevention
Health attitudes - United States Medical policy - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN | 0-309-53086-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910455734903321 |
| Washington, DC, : National Academies Press, c2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
